Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Neoleukin Therapeutics, Inc. (AQXP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Exercised (in-or-at-the-money) 57,049 options to buy @ $0
Exercised (in-or-at-the-money) 535,601 options to buy @ $0
08/17/2023 4 BAKER BROS. ADVISORS LP (10% Owner) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Bought 143,519 shares @ $0.6308, valued at $90.5k
Bought 1,740,581 shares @ $0.6308, valued at $1.1M
Bought 358 shares @ $0.665, valued at $238.1
Bought 4,342 shares @ $0.665, valued at $2.9k
Bought 17,124 shares @ $0.6805, valued at $11.7k
Bought 207,676 shares @ $0.6805, valued at $141.3k
Bought 366 shares @ $0.6828, valued at $249.9
Bought 4,434 shares @ $0.6828, valued at $3k
Bought 7,676 shares @ $0.6924, valued at $5.3k
Bought 93,091 shares @ $0.6924, valued at $64.5k
Bought 5,041 shares @ $0.6928, valued at $3.5k
08/14/2023 4 Smith Sean Michael (Interim CFO, Prin Acct Off) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Sold 1,323 shares @ $0.6184, valued at $818.1
Exercised 5,000 restricted stock units @ $0
06/12/2023 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
06/09/2023 4 SIMPSON TODD E (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
06/09/2023 4 PALEKAR ROHAN (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
06/09/2023 4 Noonberg Sarah B. (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
06/09/2023 4 Lavelle Erin (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
06/09/2023 4 Babler Martin (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
04/04/2023 4 Patel Priti (Former Chief Medical Officer) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Sold 3,769 shares @ $0.6919, valued at $2.6k
Exercised 10,000 restricted stock units @ $0
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2022 4 Patel Priti (Chief Medical Officer) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 250,000 options to buy @ $0.99, valued at $247.5k
08/04/2022 4 DRACHMAN JONATHAN G (President and CEO) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 350,000 options to buy @ $0.99, valued at $346.5k
08/04/2022 4 Cochener Donna (General Counsel, SVP Legal) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $0.99, valued at $99k
05/16/2022 4 SIMPSON TODD E (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.07, valued at $26.8k
05/16/2022 4 PALEKAR ROHAN (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.07, valued at $26.8k
05/16/2022 4 Noonberg Sarah B. (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.07, valued at $26.8k
05/16/2022 4 Lavelle Erin (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.07, valued at $26.8k
05/16/2022 4 Babler Martin (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.07, valued at $26.8k
05/16/2022 4 BAKER BROS. ADVISORS LP (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.07, valued at $26.8k
05/03/2022 4 Patel Priti (Chief Medical Officer) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Sold 5,538 shares @ $1.2186, valued at $6.7k
Exercised 10,000 restricted stock units @ $0
03/15/2022 4 Cochener Donna (General Counsel, SVP Legal) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 400,000 options to buy @ $1.81, valued at $724k
03/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Smith Sean Michael (Principal Accounting Officer) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 80,000 options to buy @ $2.72, valued at $217.6k
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/26/2021 4 DRACHMAN JONATHAN G (President and CEO) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Bought 100,000 shares @ $6.111, valued at $611.1k
Bought 25,000 shares @ $6.449, valued at $161.2k
Bought 25,000 shares @ $6.449, valued at $161.2k
08/05/2021 4 Walkey Carl (Senior Vice President) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $6.8, valued at $680k
08/05/2021 4 Vance Holly (General Counsel) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $6.8, valued at $680k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy